Kenneth Clark - Insider Trading & Ownership

Entity
Individual
Location
C/O Pharmacyclics, Inc., 995 East Arques Ave., Sunnyvale, CA
Summary
The estimated net worth of Kenneth Clark is at least $156K dollars as of January 6, 2025. Kenneth Clark is the Director of Summit Therapeutics Inc. and owns shares of Summit Therapeutics Inc. (SMMT) stock worth about $156K.
All Insider Reports
All Insider Reports

Ownership of Kenneth Clark

Insider Transactions Reported by Kenneth Clark:

* An asterisk sign (*) next to the price indicates that the price is likely invalid.